Proposed adjustments in robustness tests improve model testing in biomedical applications, suggesting integration with regulatory frameworks.
The rise of biomedical foundation models creates new hurdles in model testing and authorization, given their broad capabilities and susceptibility to complex distribution shifts. We suggest tailoring robustness tests according to task-dependent priorities and propose to integrate granular notions of robustness in a predefined specification to guide implementation. Our approach facilitates the standardization of robustness assessments in the model lifecycle and connects abstract AI regulatory frameworks with concrete testing procedures.
No takes yet. Share an insight, caveat, or question.
Xian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: